P930021S024

None

FDA Premarket Approval P930021 S024

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP930021S024
Classification NameNone
Applicant
PMAP930021
SupplementS024

Supplemental Filings

Supplement NumberDateSupplement Type
P930021Original Filing
S025 2019-08-09 30-day Notice
S024
S023 2018-11-02 135 Review Track For 30-day Notice
S022 2018-10-24 135 Review Track For 30-day Notice
S021 2018-10-22 135 Review Track For 30-day Notice
S020 2018-05-10 30-day Notice
S019 2018-04-13 135 Review Track For 30-day Notice
S018 2017-12-15 135 Review Track For 30-day Notice
S017 2016-09-09 135 Review Track For 30-day Notice
S016 2016-04-06 Normal 180 Day Track
S015 2015-06-29 30-day Notice
S014 2015-03-02 Normal 180 Day Track
S013 2012-09-19 Normal 180 Day Track No User Fee
S012 2009-01-12 Normal 180 Day Track No User Fee
S011 2008-03-27 Normal 180 Day Track
S010 2007-10-09 Real-time Process
S009 2006-04-11 Special (immediate Track)
S008 2002-09-13 Normal 180 Day Track
S007 2002-07-01 Normal 180 Day Track
S006 2002-06-17 Normal 180 Day Track
S005 2000-07-26 Normal 180 Day Track
S004 2000-03-09 Real-time Process
S003 1999-05-20 Normal 180 Day Track
S002 1999-01-26 Normal 180 Day Track
S001 1998-01-05 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
07630031700100 P930021 013
07630031700087 P930021 013
07630031700025 P930021 013
07630031730046 P930021 020
07630031730039 P930021 020
07630031730022 P930021 020
07630031730015 P930021 020
07630031729989 P930021 020

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.